Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 7248Neoplasms 4547Prostatic Neoplasms 3494Colorectal Neoplasms 2941Carcinoma, Non-Small-Cell Lung 2832Lung Neoplasms 2548Leukemia, Myeloid, Acute 1983Pancreatic Neoplasms 1875Multiple Myeloma 1812Carcinoma, Hepatocellular 1735Neoplasm Metastasis 1587Stomach Neoplasms 1502Lymphoma 1457Head and Neck Neoplasms 1437Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Brain Neoplasms 1374Melanoma 1349Ovarian Neoplasms 1347Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1140Uterine Cervical Neoplasms 1098Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 938Lymphoma, Large B-Cell, Diffuse 933Squamous Cell Carcinoma of Head and Neck 921

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Safety Issues × Clear all
NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

NCT03620435 2018-08-13

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Unknown
25 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡